# Thymulin FAQ: Common Questions About the Zinc-Bound Thymic Peptide

> Thymulin FAQ: what it is, why it needs zinc, whether there is a thymulin supplement, how it differs from thymosin alpha-1, and what the research record actually shows. Direct, cited answers.

Direct answers about thymulin — identity, zinc-dependence, immune findings, dosing context, and the honest gaps. Cited where a number is claimed.

## What is thymulin?

Thymulin is a zinc-dependent thymic nonapeptide hormone produced exclusively by thymic epithelial cells; it is biologically active only when bound to zinc in a 1:1 ratio [1]. It is studied as a research peptide and is not FDA-approved. It is distinct from thymosin alpha-1 and thymosin beta-4 [15].

## What is thymulin peptide?

Thymulin peptide is a linear nonapeptide — sequence pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn — that becomes biologically active only after binding one zinc ion per molecule [1]. Its molecular weight is 858.86 Da and its formula is C33H54N12O15. The zinc-free form has no activity until zinc is restored [2].

## Is thymulin the same as serum thymic factor (FTS)?

Yes, in lineage. "Serum thymic factor" (FTS) is the original name for the same peptide. FTS denotes the zinc-free peptide; once zinc binds in a 1:1 ratio, the active form was named thymulin [1]. The high-affinity receptors described as FTS receptors in 1980 are the same molecule's receptors [7].

## What is the amino acid sequence of thymulin?

Thymulin is the nonapeptide pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn (also written <Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn), with molecular formula C33H54N12O15 and a molecular weight near 858.86 Da [2]. "Nonapeptide" means a chain of nine amino-acid residues.

## Why does thymulin need zinc to work?

Binding one zinc ion per peptide drives a specific active conformation; the zinc-free apopeptide is inactive. In the original work, chelating zinc abolished activity and adding it back restored it at a 1:1 metal-to-peptide ratio [1], and antibodies to the zinc-coupled epitope block activity [4].

## What is the role of zinc in thymulin activity?

Zinc is obligatory: it binds the peptide 1:1 to create the active three-dimensional epitope [4]. Serum thymulin activity tracks zinc status and is corrected by zinc repletion in animals and in humans with mild zinc deficiency [5][2]. Without bound zinc, the peptide is inert.

## Is thymulin a hormone?

Yes. Thymulin is described as a thymic peptide hormone: it is secreted by thymic epithelial cells and acts on distant targets, including a hypophysiotropic (pituitary-directed) action within the thymus-neuroendocrine axis [11][10]. Its classical target is the maturing T-cell compartment [3].

## Is thymulin produced naturally in the body?

Yes. Thymulin is produced exclusively by thymic epithelial (reticulo-epithelial) cells; circulating levels are present from birth, peak in childhood, and decline with age and zinc deficiency [11]. It is an endogenous hormone, not a foreign molecule.

## What does thymulin do in the body?

Endogenously, thymulin contributes to T-lymphocyte differentiation and immune-cell modulation [3][6] and acts as a hypophysiotropic peptide in a bidirectional thymus-neuroendocrine axis [11][10]. Circulating levels peak in childhood and fall with age and zinc deficiency [11].

## How is thymulin different from thymosin alpha-1?

They are distinct thymic peptides. Thymulin is a zinc-dependent nonapeptide whose activity requires bound zinc 1:1 [1]; thymosin alpha-1 is a separate, larger peptide with its own research literature. Thymulin's findings should never be attributed to thymosin alpha-1 or to thymalin, a bovine thymic complex [15].

## What are the benefits of thymulin peptide?

In research models, thymulin has shown anti-inflammatory, immune-modulating, and — via gene therapy — lung-protective effects [13][6][14]. All are study findings in named species or in-vitro systems, not demonstrated human benefits, and the human evidence base is sparse and dated.

## What are the benefits of thymulin?

Documented research effects include T-cell differentiation [6], suppression of pro-inflammatory cytokines and NF-kB/JNK signaling [13], high-affinity receptor binding on T-lineage cells [7], and immunomodulation in zinc-deficiency and malnutrition models [5][8] — all in animals or cells.

## Does thymulin boost the immune system?

Thymulin's classical role is driving T-cell differentiation and modulating immune-cell function [6][3]; in zinc-deficiency and malnutrition models, restoring zinc-bound thymulin was associated with improved immune measures [5][8]. This is research-model evidence, not a clinical immune-boosting claim.

## Does thymulin reduce inflammation?

In LPS-treated mice, thymulin lowered plasma pro-inflammatory cytokines and modulated NF-kB and SAPK/JNK signaling when given daily for two weeks before challenge [13]. These are animal findings, not evidence of an anti-inflammatory effect in people.

## Does thymulin have anti-aging effects?

Circulating thymulin declines with age and zinc deficiency [11], which frames thymulin within zinc-dependent immunosenescence research [5][9]. That is a research framing, not an anti-aging therapy for humans. No human trial supports an anti-aging use.

## Is thymulin studied for pain relief?

In rodent inflammatory and endotoxin models, thymulin and a peptide analog of thymulin (PAT) have been studied for anti-hyperalgesic effects, with reviews noting CNS anti-inflammatory and analgesic activity [11]. These are animal findings only, not a demonstrated pain treatment in people.

## Is there a thymulin supplement?

No. Thymulin is a research peptide, not an FDA-approved drug and not a dietary supplement. There is no approved or established thymulin supplement product. Most evidence is preclinical, and the limited human data are dated [12]. This site is editorial and sells nothing.

## What is the dosage of thymulin peptide?

There is no established human dose. Studies report research doses in animals and cells — for example picomolar concentrations in vitro [10] and nanogram-to-low-microgram amounts in rodents [13]. These are study parameters, not protocols for people.

## How is thymulin administered in research?

In animal and in-vitro studies, thymulin has been given by intraperitoneal, subcutaneous, and intracerebroventricular routes [13][10], with intratracheal and intramuscular delivery used for gene-therapy vectors [14][12] and a topical zinc-thymulin pilot in humans.

## Is thymulin taken as an injection?

In research, thymulin has been delivered by injection routes — intraperitoneal, subcutaneous, intracerebroventricular — in animals [13][10]; a human topical zinc-thymulin pilot used a skin formulation. There is no approved human injectable product.

## What doses of thymulin were used in animal studies?

Reported research doses include nanogram-to-low-microgram amounts given intraperitoneally or intracerebroventricularly in rodents, and roughly 100 ng/kg/day subcutaneously in a rat pulmonary study; gene-therapy work used a single vector dose [14]. In-vitro pituitary work used picomolar concentrations, maximal near 10 pM [10].

## What is the half-life of thymulin?

As a small peptide, native thymulin has a short circulating half-life, but a precise human pharmacokinetic half-life is not well established in the public literature [12]. That gap is one reason gene-therapy approaches were developed — to sustain circulating thymulin rather than redose the bare, fast-clearing peptide.

---

Reviews Thymulin reads the published thymulin record off the record — zinc-switch first, evidence tier marked, gaps left in plain view; no clinic behind the desktop and nothing here dispensed, sourced, or sold.